Characterization of antiviral resistance mutations among the Eastern Indian Hepatitis B virus infected population
Open Access
- 14 February 2013
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 10 (1) , 56
Abstract
Background: Antiviral therapy using nucleos(t)ide analogues (NAs) is an effective control measure of chronic hepatitis B virus (HBV) infection; however they need long term treatment. Presence of drug-resistance mutations may get in the way of the efficacy of antiviral therapy. Our study was aimed at defining the prevalence of HBV drug-resistance in HBVrt region in a population of 147 HBsAg positive patients. Findings: HBV/D has shown multiple types of HBVrt mutations both among treatment naïve (65.0%, 13 of 20 HBV/D) and treated patients (56.2%, 9 of 16 HBV/D). In additional, several mutations, with a suggested role in drug resistance, were detected among the treatment naïve as well as the treated patients. The mutations reported to be involved in reduction of drug effectiveness, was common among non-responders to therapy as well as among the naïve patients. Notably, classical antiviral resistance mutations (rtL80I/V-rtI169T-rtV173L-rtL180M-rtA181T/V/S-rtT184A/S/G/C-rtA194T-rtS202C /G/I -rtM204V/I-rtN236T-rtM250V) were not detected. Conclusion: The prevalence of putative NAr mutations among non responders to therapy suggests that they might have role in reduced efficacy of currently available antivirals and requires further investigations.Keywords
This publication has 18 references indexed in Scilit:
- Antiviral Resistance Mutations and Genotype-Associated Amino Acid Substitutions in Treatment-Naïve Hepatitis B Virus-Infected Individuals from the Indian SubcontinentIntervirology, 2011
- The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypesJournal of Hepatology, 2009
- Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S AntigenJournal of Virology, 2009
- Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trialsJournal of Hepatology, 2007
- The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In VitroAntimicrobial Agents and Chemotherapy, 2007
- Antiviral drug-resistant HBVHepatology, 2007
- Antiviral Drug Resistance: Clinical Consequences and Molecular AspectsSeminars in Liver Disease, 2006
- Hepatitis B virus mutations associated with antiviral therapyJournal of Medical Virology, 2006
- Cellular and virological mechanisms of HBV drug resistanceJournal of Hepatology, 2006
- Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionHepatology, 2001